In Phase 3, studies of different clinical applications may differ in both study population and outcomes.
Seroprevalence studies of different populations, especially those with differing immune responses, cannot lead except by chance to the same result.
The predictive outcome – severe hyperbilirubinemia – was defined differently in the presented studies of different strategies for risk assessment.
You study different case studies of different lawsuits against hotels.
Many physicians believe, based on previous studies of different cholesterol drugs, that lowering bad cholesterol is a known good that should lead to a reduced risk of heart problems.
The following classification derives from Zug, Vitt, and Caldwell (2001), who presented a composite phylogeny from several studies of different ancient amphibian groups.
Three studies of different mobile-device hand postures are presented.
Two case studies of different topological complexity were considered.
Studies of different microalgae also have showed varied responses to glucose or sodium acetate.
Studies of different hypersaline systems have revealed various types of limitation.
A brief review of quantum chemical studies of different active sites in zeolites is presented.
